908 related articles for article (PubMed ID: 34356767)
1. Antibiotic Susceptibility Profile of
Dégi J; Moțco OA; Dégi DM; Suici T; Mareș M; Imre K; Cristina RT
Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356767
[TBL] [Abstract][Full Text] [Related]
2. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
[TBL] [Abstract][Full Text] [Related]
3. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
[TBL] [Abstract][Full Text] [Related]
4. Changing drug resistance profile in Pseudomonas aeruginosa infection among HIV patients from 2010-2017: A retrospective study.
Swathirajan CR; Rameshkumar MR; Solomon SS; Vignesh R; Balakrishnan P
J Glob Antimicrob Resist; 2019 Mar; 16():274-277. PubMed ID: 30389636
[TBL] [Abstract][Full Text] [Related]
5. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
6. ESBL and MBL in Cefepime Resistant Pseudomonas aeruginosa: An Update from a Rural Area in Northern India.
Kotwal A; Biswas D; Kakati B; Singh M
J Clin Diagn Res; 2016 Apr; 10(4):DC09-11. PubMed ID: 27190800
[TBL] [Abstract][Full Text] [Related]
7. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
Millar BC; Rendall JC; Downey DG; Moore JE
J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
[TBL] [Abstract][Full Text] [Related]
8. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
9. Occurrence, antimicrobial susceptibility, and pathogenic factors of
Hattab J; Mosca F; Di Francesco CE; Aste G; Marruchella G; Guardiani P; Tiscar PG
Vet World; 2021 Apr; 14(4):978-985. PubMed ID: 34083949
[TBL] [Abstract][Full Text] [Related]
10. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital.
Gonlugur U; Bakici MZ; Ozdemir L; Akkurt I; Icagasioglu S; Gultekin F
Ann Clin Microbiol Antimicrob; 2003 Mar; 2():5. PubMed ID: 12665428
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.
Ekkelenkamp MB; Cantón R; Díez-Aguilar M; Tunney MM; Gilpin DF; Bernardini F; Dale GE; Elborn JS; Bayjanov JR; Fluit A
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767727
[TBL] [Abstract][Full Text] [Related]
14. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections.
Van Eldere J
J Antimicrob Chemother; 2003 Feb; 51(2):347-52. PubMed ID: 12562701
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Pseudomonas Aeruginosa and its Antibiotic Sensitivity Pattern.
Pokharel K; Dawadi BR; Bhatt CP; Gupte S
J Nepal Health Res Counc; 2019 Apr; 17(1):109-113. PubMed ID: 31110388
[TBL] [Abstract][Full Text] [Related]
16. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
Henderson A; Tan E; McCarthy KL; Paterson DL
Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
[TBL] [Abstract][Full Text] [Related]
17. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Resistance Profile of
Asamenew T; Worku S; Motbainor H; Mekonnen D; Deribe A
Ethiop J Health Sci; 2023 May; 33(3):423-432. PubMed ID: 37576170
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa.
Martín Barrasa JL; Lupiola Gómez P; González Lama Z; Tejedor Junco MT
J Vet Med B Infect Dis Vet Public Health; 2000 Apr; 47(3):191-6. PubMed ID: 10829573
[TBL] [Abstract][Full Text] [Related]
20. Identification of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from dogs with pyoderma and otitis in Korea.
Hyun JE; Chung TH; Hwang CY
Vet Dermatol; 2018 Jun; 29(3):186-e68. PubMed ID: 29575185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
